Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs

Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears, and exerted negative pressure on stocks. There were very few stock-specific catalysts, barring a few preannouncements, stock offerings, and a slew of initial public offerings.

ABT

Read More

Understanding Quest Diagnostics’s Ex-Dividend Date

On May 20, 2021, Quest Diagnostics (NYSE:DGX) announced shareholders can expect to receive a dividend payable on July 21, 2021. The stock will then go ex-dividend 1 business day(s) before the record date. Quest Diagnostics, whose current dividend payout is $0.62, has an ex-dividend date set at July 6, 2021.

DGX